Implications of Expanding Use of CAR T-Cell Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)

Video

A discussion on the clinical impact of chimeric antigen receptor (CAR) T-cell therapy in relapsed/refractor (R/R) non-Hodgkin lymphoma and the role of expanding CAR T administration into the community practice setting.

Recent Videos
Kiran Musunuru, MD, PhD, a physician-scientist and Barry J. Gertz Professor for translational research in the Perelman School of Medicine at the University of Pennsylvania and CHOP and Rebecca Ahrens-Nicklas, MD, PhD, a physician-scientist and director of the Gene Therapy for Inherited Metabolic Disorders Frontier Program at CHOP
Nicholas Giovannone, PhD, a senior principal scientist at Regeneron
Nathan Yozwiak, PhD, on Collaboration for Cell and Gene Therapy Development
Cure SMA Treatment Recommendations
Cure SMA Treatment Recommendations
Cure SMA Treatment Recommendations
James Beck, PhD, the chief scientific officer of the Parkinson’s Foundation
James Beck, PhD, the chief scientific officer of the Parkinson’s Foundation
Linda Marbán, PhD, the CEO of Capricor Therapeutics
Cassandra Gorsuch, PhD, chief scientific officer at Precision
Related Content
Around the Helix: Cell and Gene Therapy Company Updates – May 14, 2025

Around the Helix: Cell and Gene Therapy Company Updates – May 14, 2025

Noah Stansfield
May 14th 2025
Article

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

ImmunoLogic

ImmunoLogic, Episode 3: "Breaking the Brain’s Barrier: CAR T-Cells Take on Glioblastoma" With Marcela Maus, MD, PhD

Joseph A. Fraietta, PhD;Janna Minehart, MD;Marcela V. Maus, MD, PhD;Noah Stansfield;Matt Hoffman
April 8th 2025
Podcast

In Episode 3 of ImmunoLogic, Marcela Maus, MD, PhD, discussed her research on CAR-T for treating glioblastoma.

World Ovarian Cancer Day 2025: Looking Back at Progress for Cell Therapy

World Ovarian Cancer Day 2025: Looking Back at Progress for Cell Therapy

Noah Stansfield
May 8th 2025
Article

In observance of World Ovarian Cancer Day, held annually on May 8, we took a look back at news in cell therapy for ovarian cancer indications.

ImmunoLogic

ImmunoLogic, Episode 2: "Charting New Frontiers in CAR T-Cell Safety" With Bruce Levine, PhD

Joseph A. Fraietta, PhD;Janna Minehart, MD;Noah Stansfield;Matt Hoffman
March 11th 2025
Podcast

In Episode 2 of ImmunoLogic, Bruce Levine, PhD, discussed the current the risk-benefit-ratio for CAR-T therapy.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – May 2, 2025

Noah Stansfield
May 2nd 2025
Article

Review top news and interview highlights from the week ending May 2, 2025.

Data Roundup: April 2025 Features Updates for Cardiomyopathy Gene Therapy, Myasthenia Gravis CAR-T, and More

Data Roundup: April 2025 Features Updates for Cardiomyopathy Gene Therapy, Myasthenia Gravis CAR-T, and More

Noah Stansfield
May 2nd 2025
Article

Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.

© 2025 MJH Life Sciences

All rights reserved.